The Expertise to Achieve Maximum Product Potential ICON’s Commercialisation & Outcomes practices provide insights to clients on strategies and execution for long-term value through customised engagements that fit the compound, the company and the market, maximising products' success and their benefits to patients’ health. The combined strengths in our scientific practices and operational delivery teams offer tremendous opportunity to harness expertise and capabilities from multiple disciplines at once, or in sequence, creating a stronger and more persistent focus on product value and commercial success. Specialty practices directed toward product commercialisation include: Peri-approval & Observational Research Pricing & Market Access Health Economics Patient Reported Outcomes Epidemiology Electronic Clinical Outcomes Assessment Language Services ICON Commercialisation & Outcomes ultimately helps clients make the best decisions based on academically rigorous and commercially relevant expertise and services early in development so that they can introduce the highest value product into the market place in the shortest time.
| Website | http://www.pricespective.com |
| Revenue | $23 million |
| Employees | 12 (7 on RocketReach) |
| Founded | 2003 |
| Address | 460 NORRISTOWN Rd, Blue Bell, Pennsylvania 19422, US |
| Phone | +1 610-629-6118 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Management Consulting, Pharmaceutical Pricing, Business Services, Payer Strategy, Market Access, Commercial Assessment, Product Valuations, Payer Implementation, Due Dilligence, Business Development |
| Web Rank | 323630 |
| Web Visits | 94980 |
| Keywords | Icon, Icon Plc, Icon Remote, Icon Clinical Research, Quality Management Corporate, Artifical Intellifegence In Healthcare Subsectors, Promoting The Use Of Complex Innovative Designs In Clinical Trials, How Monetizing Of Data Occurs In Healthcare, Validation Of Flow Cytometry Methods, Mimetas |
| Competitors | Deloitte, McKinsey & Company, Optum, IQVIA, Parexel, Kantar, ZS, EVERSANA, Clarivate for Intellectual Property, PharmaLex +43 more (view full list) |
| SIC | SIC Code 874 Companies, SIC Code 87 Companies |
Looking for a particular PriceSpective LLC employee's phone or email?
The PriceSpective LLC annual revenue was $23 million in 2026.
Heidi Hefner is the Director of PriceSpective LLC.
7 people are employed at PriceSpective LLC.
PriceSpective LLC is based in Blue Bell, Pennsylvania.
The SIC codes for PriceSpective LLC are [874, 87].